A noninvasive technology that uses sound waves to destroy tumors gets a tailwind from VC interest in late-stage medtechs By Brian Gormley HistoSonics’ technology, which received FDA clearance in October 2023, destroys liver tumors using high-intensity sound waves. Photo: HistoSonics With investor interest in later-stage medical-technology companies accelerating, venture capitalists have supplied $102 million in […]